The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Vermont state Prescription Drug Monitoring Program (PDMP).
The acronym for the Vermont PDMP is VPMS. It is administered by the State Department of Health. The email address is provided, along with the URLs for the main website and related websites for enrollment, query, data upload, and statistics. Contact information is provided for the Program Manager and the VPMS Analyst. In 2020, the state population was 643,503, and there were 4,611 DEA-registered prescribers and 143 DEA-registered dispensers. Seventeen types of reports are listed as available from the PDMP. Funding for the PDMP is from a CDC grant. The 2021 budget amount is not provided. There are two staff members, one for technical work and one for analytical/epidemiological work. Key dates for the establishment and development of the PDMP are listed, and access information addresses statutes and rules on PDMP responsibilities and policies. Twelve “miscellaneous capabilities and policies” of the PDMP are listed. The PDMP’s data retention policy requires that all information be purged after 6 years. Requirements for PDMP accounts are reported, distinguished for prescribers, dispensers, the Regulatory Board, and law enforcement agencies. Law enforcement agency access to patient information requires a subpoena or court order/approval and a written request. Criteria for a query are provided. Enrollment in and use of the PDMP are required for prescribers and dispensers. Veterinarians are not allowed to enroll with the PDMP as either requestors or submitters. Drug data monitored or accessible is for those listed in Schedules II-IV. Also monitored are naloxone/narcan administration and dispensing and fatal drug overdoses. PDMP technological capabilities are profiled, and a chart shows types of requestors for whom solicited and unsolicited reports are available.
810 Seventh Street NW, Washington, DC 20531, United States